Abstract:Small-molecule drug design is a complex and iterative decision-making process relying on pre-existing knowledge and driven by experimental data. Low-molecular-weight chemicals represent an attractive therapeutic option, as they are readily accessible to organic synthesis and can easily be characterized.1 Their potency as well as pharmacokinetic and pharmacodynamic properties can be systematically and rationally investigated and ultimately optimized via expert science behind medicinal chemistry and methods of computer-aided drug design (CADD). In recent years, significant advances in molecular modeling techniques have afforded a variety of tools to effectively identify potential binding pockets on prospective targets, to map key interactions between ligands and their binding sites, to construct and assess energetics of the resulting complexes, to predict ADMET properties of candidate compounds, and to systematically analyze experimental and computational data to derive meaningful structure-activity relationships leading to the creation of a drug candidate. This Perspective describes a real case of a drug discovery campaign accomplished in a relatively short time with limited resources. The study integrated an arsenal of available molecular modeling techniques with an array of experimental tools to successfully develop a novel class of potent and selective androgen receptor inhibitors with a novel mode of action. It resulted in the largest academic licensing deal in Canadian history, totaling $142M. This project exemplifies the importance of team science, an integrative approach to drug discovery, and the use of best practices in CADD. We posit that the lessons learned and best practices for executing an effective CADD project can be applied, with similar success, to many drug discovery projects in both academia and industry.

Computer-Aided Drug Design: Lead Discovery And Optimization

Advances in Computational Structure-Based Drug Design and Application in Drug Discovery.

Current perspectives and trend of computer-aided drug design: a review and bibliometric analysis

Applications of Computer-Aided Drug Design

A Guide to In Silico Drug Design

Past, Present, and Future Perspectives on Computer-Aided Drug Design Methodologies

COMPUTER AIDED DRUG DESIGN: AN OVERVIEW

i Drug: a web-accessible and interactive drug discovery and design platform

Computer-Aided Drug Design and Drug Discovery: A Prospective Analysis

Research on the application of computer in drug design

Computer-Aided Drug Design towards New Psychotropic and Neurological Drugs

Computer-aided drug design using in the modernization of traditional Chinese medicine

Recent updates in click and computational chemistry for drug discovery and development

The New Era of Drug Discovery: The Power of Computer-aided Drug Design (CADD)

Anesthetic drug discovery with computer-aided drug design and machine learning

Role of Computer-Aided Drug Design in Drug Development

Current Developments of Computer-Aided Drug Design

An Updated Review on Developing Small Molecule Kinase Inhibitors Using Computer-Aided Drug Design Approaches

Deep Lead Optimization: Leveraging Generative AI for Structural Modification

Best Practices of Computer-Aided Drug Discovery: Lessons Learned from the Development of a Preclinical Candidate for Prostate Cancer with a New Mechanism of Action

Synthesis and Photo Electrochemical Characterization of an Extended π-Conjugated Heteroleptic Ruthenium (II) Complex